Clinical Trial Update: Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for SC291 in severe B-cell–mediated autoimmune diseases; the study is active but not recruiting and includes systemic lupus erythe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antineutrophil Cytoplasmic Antibody-associated Vasculitis
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis
• Systemic Lupus Erythematosus

Drugs mentioned

• SC291

Snippet

Sponsor: Sana Biotechnology | Conditions: Lupus Erythematosus, Systemic Lupus Erythematosus | Phase 1 | Status: ACTIVE_NOT_RECRUITING